SCHEMBL3690478

SCHEMBL3690478

N=C(N)Sc1ccccc1SC(=N)N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 6/20 0.53
▸ NOS1 P29475 5/20 0.44
▸ NOS3 P29474 2/20 0.44
▸ NOS2 P35228 2/20 0.44
▸ F2 P00734 1/20 0.42
▸ F10 P00742 1/20 0.42
▸ F12 P00748 1/20 0.42
▸ F7 P08709 1/20 0.42
▸ F3 P13726 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ BLM P54132 2/20 0.40
▸ KMT2A Q03164 3/20 0.39
▸ PRSS1 P07477 1/20 0.39
▸ PRSS2 P07478 1/20 0.39
▸ C1S P09871 1/20 0.39
▸ PRSS3 P35030 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ LMNA P02545 4/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ HTT P42858 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL4005261 0.97 IDO1 (0.52) IDO1NOS1NOS3NOS2F2
SCHEMBL9824740 0.84 IDO1 (0.46) IDO1NOS1NOS3NOS2F2
SCHEMBL10393355 0.76 IDO1 (0.48) IDO1NOS1NOS3NOS2F2
SCHEMBL29459637 0.71 IDO1 (1.00) IDO1KMT2AMAPTALDH1A1MEN1
SCHEMBL6082138 0.71 IDO1 (1.00) IDO1KMT2AMAPTALDH1A1MEN1
Iodide SCHEMBL6082236 0.70 IDO1 (0.97) IDO1ALDH1A1
SCHEMBL2810294 0.69 SLC11A2 (0.43) IDO1NOS1NOS3NOS2F2
Iodide SCHEMBL2807740 0.67 SLC11A2 (0.42) IDO1NOS1NOS3NOS2F2
Hydrochloric Acid SCHEMBL11673060 0.66 LMNA (0.51) IDO1NOS1NOS3NOS2PKM
Hydrochloric Acid SCHEMBL8137241 0.66 F12 (0.37) IDO1NOS1F12KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010005851-A1 COMBINATION THERAPY FOR TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2010-01-14 — — WO claimed
EP-2068855-A2 AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2009-06-17 — — EP claimed
WO-2008151288-A2 AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-12-11 — — WO claimed
WO-2010005851-A1 COMBINATION THERAPY FOR TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2010-01-14 — — WO disclosed
EP-2068855-A2 AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2009-06-17 — — EP disclosed
WO-2008151288-A2 AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-12-11 — — WO disclosed
Send feedback